In the PROG 95-09 trial, higher-dose radiation therapy improved the 10-year biochemical recurrence rate among patients with localized prostate cancer without worsening patient-reported quality-of-life outcomes. This study provides valuable information on health-related quality of life associated with high-dose radiation therapy for prostate cancer, which may assist physicians when counseling patients on their available treatment options.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Talcott, J. A. et al. Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer. JAMA 303, 1046–1053 (2010).
Zietman, A. L. et al. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from Proton Radiation Oncology Group/American College of Radiology 95–09. J. Clin. Oncol. 28, 1106–1111 (2010).
Wei, J. T., Dunn, R. L., Litwin, M. S., Sandler, H. M. & Sanda, M. G. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56, 899–905 (2000).
Miller, D. C. et al. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J. Clin. Oncol. 23, 2772–2780 (2005).
De Meerleer, G. O. et al. Intensity-modulated radiation therapy for prostate cancer: late morbidity and results on biochemical control. Radiother. Oncol. 82, 160–166 (2007).
Deger, S. et al. High dose rate (HDR) brachytherapy with conformal radiation therapy for localized prostate cancer. Eur. Urol. 47, 441–448 (2005).
Zelefsky, M. J. et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int. J. Radiat. Oncol. Biol. Phys. 53, 1111–1116 (2002).
Namiki, S. et al. Five-year follow-up of health-related quality of life after intensity-modulated radiation therapy for prostate cancer. Jpn J. Clin. Oncol. 39, 732–738 (2009).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Montgomery, J. Patient-reported functional outcomes with radiation therapy. Nat Rev Urol 7, 537–538 (2010). https://doi.org/10.1038/nrurol.2010.159
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2010.159
